SRC and neoplasm: We have previously shown that expression of CD24 is a mechanism that can activate Src kinase activity in the tumor context [14], consistent with the observation that the Ras/ERK/MAPK pathway that is activated by Src [43] is downregulated as a consequence of targeting of CD24 [27].